Gene Expression Profiling of Gastric Cancer

Journal of Proteomics and Bioinformatics

Volumn 4, Issue 4, 2011, Pages 074-082

  Marimuthu, Arivusudar ^a,b   Jacob, Harrys K C ^a,b,c   Jakharia, Aniruddha ^d,k   Subbannayya, Yashwanth ^a,e   Keerthikumar, Shivakumar ^a   Kashyap, Manoj Kr ^a,f   Goel, Renu ^a,f   Balakrishnan, Lavanya ^a,f   Dwivedi, Sutopa ^a,g   Pathare, Swapnali ^h   Dikshit, Jyoti Bajpai ^h   Maharudraiah, Jagadeesha ^a,i   Singh, Sujay ^j,k   Sameer Kumar, Ghantasala S ^a,f   Vijayakumar, M ^l   Kumar, Kariyanakatte Veeraiah Veerendra ^l   Premalatha, Chennagiri Shrinivasamurthy ^l   Tata, Pramila ^h   Hariharan, Ramesh ^h   Roa, Juan Carlos ^m   Prasad, T S K ^a,b   Chaerkady, Raghothama ^a,b,c   Rekha, Vijay Kr ^l   Pandey, Akhilesh ^c,e   more..

^a Institute of Bioinformatics   (India)

^b MANIPAL UNIVERSITY   (India)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d GAUHATI UNIVERSITY   (India)

^e RAJIV GANDHI UNIVERSITY OF HEALTH SCIENCES   (India)

^f KUVEMPU UNIVERSITY   (India)

^g AMRITA UNIVERSITY   (India)

^h Strand Life Sciences ^*  (India)

ⁱ RajaRajeswari Medical College   (India)

^j Imgenex Corporation   (United States)

^k Imgenex India   (India)

^l KIDWAI MEMORIAL INSTITUTE OF ONCOLOGY   (India)

^m UNIVERSIDAD DE LA FRONTERA   (Chile)

more..

Author keywords

DNA microarray; Gastric cancer; GeneSpring GX; Immunohistochemistry

Indexed keywords

OLIGONUCLEOTIDE; TUMOR MARKER;

ARTICLE; CELL ADHESION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE OVEREXPRESSION; GENETIC ASSOCIATION; GENETIC IDENTIFICATION; HETEROZYGOTE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; NUCLEOTIDE SEQUENCE; ONCOGENE; STOMACH ADENOCARCINOMA; TESTICAN 1 GENE; UPREGULATION; VILLIN 1 GENE;

EID: 79955496492     PISSN: None     EISSN: 0974276X     Source Type: Journal    
DOI: 10.4172/jpb.1000170     Document Type: Article

References (54)

1. Hamilton JP, Meltzer SJ (2006) A review of the genomics of gastric cancer. Clin Gastroenterol Hepatol 4: 416-425.
2. Lauren P (1965) The Two Histological Main Types Of Gastric Carcinoma: Diffuse And So-Called Intestinal-Type Carcinoma. An Attempt At A Histo-Clinical Classification. Acta Pathol Microbiol Scand 64: 31-49.
3. Miwa H, Go MF, Sato N (2002) H. pylori and gastric cancer: the Asian enigma. Am J Gastroenterol 97: 1106-1112.
4. Fuchs CS, Mayer RJ (1995) Gastric carcinoma. N Engl J Med 333: 32-41.
5. Parkin DM, Bray F, Ferlay J, Pisani P (2002) Global cancer statistics. CA Cancer J Clin 55: 74-108.
6. Shah MA (2006) Gastric cancer: an update. Curr Oncol Rep 8: 183-191.
7. Jinawath N, Furukawa Y, Hasegawa S, Li M, Tsunoda T, et al. (2004) Comparison of gene-expression profiles between diffuse-and intestinal-type gastric cancers using a genome-wide cDNA microarray. Oncogene 23: 6830-6844.
8. Norsett KG, Laegreid A, Midelfart H, Yadetie F, Erlandsen SE, et al. (2004) Gene expression based classification of gastric carcinoma. Cancer Lett 210: 227-237.
9. Wang CS, Lin KH, Chen SL, Chan YF, Hsueh S (2004) Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance. Br J Cancer 91: 1924-1930.
10. Wang L, Zhu JS, Song MQ, Chen GQ, Chen JL (2006) Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray. World J Gastroenterol 12: 6949-6954.
11. Wu CM, Lee YS, Wang TH, Lee LY, Kong WH, et al. (2006) Identification of differential gene expression between intestinal and diffuse gastric cancer using cDNA microarray. Oncol Rep 15: 57-64.
12. Hippo Y, Taniguchi H, Tsutsumi S, Machida N, Chong JM, et al. (2002) Global gene expression analysis of gastric cancer by oligonucleotide microarrays. Cancer Res 62: 233-240.
13. Terashima M, Maesawa C, Oyama K, Ohtani S, Akiyama Y, Ogasawara S, et al. (2005) Gene expression profiles in human gastric cancer: expression of maspin correlates with lymph node metastasis. Br J Cancer 92: 1130-1136.
14. Myllykangas S, Junnila S, Kokkola A, Autio R, Scheinin I, et al. (2008) Integrated gene copy number and expression microarray analysis of gastric cancer highlights potential target genes. Int J Cancer 123: 817-825.
15. Sentani K, Oue N, Sakamoto N, Arihiro K, Aoyagi K, Sasaki H, et al. (2008) Gene expression profiling with microarray and SAGE identifies PLUNC as a marker for hepatoid adenocarcinoma of the stomach. Mod Pathol 21: 464-475.
16. Tsukamoto Y, Uchida T, Karnan S, Noguchi T, Nguyen LT, et al. (2008) Genome-wide analysis of DNA copy number alterations and gene expression in gastric cancer. J Pathol 216: 471-482.
17. Power DG, Kelsen DP, Shah MA (2010) Advanced gastric cancer-Slow but steady progress. Cancer Treat Rev 36: 384-392.
18. Hu YC, Lam KY, Law S, Wong J, Srivastava G (2001) Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC. Clin Cancer Res 7: 2213-2221.
19. Chen KN, Gu ZD, Ke Y, Li JY, Shi XT, et al. (2005) Expression of 11 HOX genes is deregulated in esophageal squamous cell carcinoma. Clin Cancer Res 11: 1044-1049.
20. Kashyap MK, Marimuthu A, Kishore CJ, Peri S, Keerthikumar S, et al. (2009) Genomewide mRNA profiling of esophageal squamous cell carcinoma for identification of cancer biomarkers. Cancer Biol Ther 8: 36-46.
21. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550.
22. Lal-Nag M, Morin PJ (2009) The claudins. Genome Biol 10: 235.
23. Jung H, Jun KH, Jung JH, Chin HM, Park WB (2010) The Expression of Claudin-1, Claudin-2, Claudin-3, and Claudin-4 in Gastric Cancer Tissue. J Surg Res.
24. Rendon-Huerta E, Teresa F, Teresa GM, Xochitl GS, Georgina AF, et al. (2010) Distribution and expression pattern of claudins 6, 7, and 9 in diffuse-and intestinal-type gastric adenocarcinomas. J Gastrointest Cancer 41: 52-59.
25. Resnick MB, Gavilanez M, Newton E, Konkin T, Bhattacharya B, et al. (2005) Claudin expression in gastric adenocarcinomas: a tissue microarray study with prognostic correlation. Hum Pathol 36: 886-892.
26. Dai N, Bao Q, Lu A, Li J (2007) Protein expression of osteopontin in tumor tissues is an independent prognostic indicator in gastric cancer. Oncology 72: 89-96.
27. Imano M, Satou T, Itoh T, Sakai K, Ishimaru E, et al. (2009) Immunohistochemical expression of osteopontin in gastric cancer. J Gastrointest Surg 13: 1577-1582.
28. Song G, Ouyang G, Mao Y, Ming Y, Bao S, et al. (2009) Osteopontin promotes gastric cancer metastasis by augmenting cell survival and invasion through Akt-mediated HIF-1alpha up-regulation and MMP9 activation. J Cell Mol Med 13: 1706-1718.
29. Junnila S, Kokkola A, Mizuguchi T, Hirata K, Karjalainen-Lindsberg ML, et al. (2010) Gene expression analysis identifies over-expression of CXCL1, SPARC, SPP1, and SULF1 in gastric cancer. Genes Chromosomes Cancer 49: 28-39.
30. Motoyama K, Inoue H, Nakamura Y, Uetake H, Sugihara K, et al. (2008) Clinical significance of high mobility group A2 in human gastric cancer and its relationship to let-7 microRNA family. Clin Cancer Res 14: 2334-2340.
31. Zhang X, Yang JJ, Kim YS, Kim KY, Ahn WS, et al. (2010) An 8-gene signature, including methylated and down-regulated glutathione peroxidase 3, of gastric cancer. Int J Oncol 36: 405-414.
32. Nakamura E, Iwakawa M, Furuta R, Ohno T, Satoh T, et al. (2009) Villin1, a novel diagnostic marker for cervical adenocarcinoma. Cancer Biol Ther 8: 1146-1153.
33. Lan Y, Ovitt CE, Cho ES, Maltby KM, Wang Q, et al. (2004) Odd-skipped related 2 (Osr2) encodes a key intrinsic regulator of secondary palate growth and morphogenesis. Development 131: 3207-3216.
34. Wu I, Moses MA (2003) BNF-1, a novel gene encoding a putative extracellular matrix protein, is overexpressed in tumor tissues. Gene 311: 105-110.
35. Namkoong H, Shin SM, Kim HK, Ha SA, Cho GW, et al. (2006) The bone morphogenetic protein antagonist gremlin 1 is overexpressed in human cancers and interacts with YWHAH protein. BMC Cancer 6: 74.
36. Sneddon JB, Zhen HH, Montgomery K, van de Rijn M, Tward AD, et al. (2006) Bone morphogenetic protein antagonist gremlin 1 is widely expressed by cancer-associated stromal cells and can promote tumor cell proliferation. Proc Natl Acad Sci USA 103: 14842-14847.
37. Abrams CK, Hamosh M, Lee TC, Ansher AF, Collen MJ, et al. (1988) Gastric lipase: localization in the human stomach. Gastroenterology 95: 1460-1464.
38. Miller C (2000) An overview of the potassium channel family. Genome Biol 1: REVIEWS0004.
39. Roepke TK, Purtell K, King EC, La Perle KM, Lerner DJ, et al. (2010) Targeted deletion of Kcne2 causes gastritis cystica profunda and gastric neoplasia. PLoS One 5: e11451.
40. Yanglin P, Lina Z, Zhiguo L, Na L, Haifeng J, et al. (2007) KCNE2, a downregulated gene identified by in silico analysis, suppressed proliferation of gastric cancer cells. Cancer Lett 246: 129-138.
41. Voulgari A, Pintzas A (2009) Epithelial-mesenchymal transition in cancer metastasis: mechanisms, markers and strategies to overcome drug resistance in the clinic. Biochim Biophys Acta 1796: 75-90.
42. Khurana S, George SP (2008) Regulation of cell structure and function by actin-binding proteins: villin's perspective. FEBS Lett 582: 2128-2139.
43. Osborn M, Mazzoleni G, Santini D, Marrano D, Martinelli G, et al. (1988) Villin, intestinal brush border hydrolases and keratin polypeptides in intestinal metaplasia and gastric cancer; an immunohistologic study emphasizing the different degrees of intestinal and gastric differentiation in signet ring cell carcinomas. Virchows Arch A Pathol Anat Histopathol 413: 303-312.
44. Moll R, Robine S, Dudouet B, Louvard D (1987) Villin: a cytoskeletal protein and a differentiation marker expressed in some human adenocarcinomas. Virchows Arch B Cell Pathol Incl Mol Pathol 54: 155-169.
45. Tian MM, Zhao AL, Li ZW, Li JY (2007) Phenotypic classification of gastric signet ring cell carcinoma and its relationship with clinicopathologic parameters and prognosis. World J Gastroenterol 13: 3189-3198.
46. Bonnet F, Perin JP, Maillet P, Jolles P, Alliel PM (1992) Characterization of a human seminal plasma glycosaminoglycan-bearing polypeptide. Biochem J 288: 565-569.
47. Edgell CJ, BaSalamah MA, Marr HS (2004) Testican-1: a differentially expressed proteoglycan with protease inhibiting activities. Int Rev Cytol 236: 101-122.
48. Colin C, Baeza N, Bartoli C, Fina F, Eudes N, et al. (2006) Identification of genes differentially expressed in glioblastoma versus pilocytic astrocytoma using Suppression Subtractive Hybridization. Oncogene 25: 2818-2826.
49. Wlazlinski A, Engers R, Hoffmann MJ, Hader C, Jung V, et al. (2007) Down regulation of several fibulin genes in prostate cancer. Prostate 67: 1770-1780.
50. Leja J, Essaghir A, Essand M, Wester K, Oberg K, et al. (2009) Novel markers for enterochromaffin cells and gastrointestinal neuroendocrine carcinomas. Mod Pathol 22: 261-272.
51. (1993) An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. Lancet 341: 1359-1362.
52. Matsuzaki S, Tanaka F, Mimori K, Tahara K, Inoue H, et al. (2009) Clinicopathologic significance of KIAA1199 overexpression in human gastric cancer. Ann Surg Oncol 16: 2042-2051.
53. Song SY, Son HJ, Kim MH, Nam ES, Rhee JC, et al. (2007) Prognostic significance of maspin expression in human gastric adenocarcinoma. Hepatogastroenterology 54: 973-976.
54. Yang S, Shin J, Park KH, Jeung HC, Rha SY, et al. (2007) Molecular basis of the differences between normal and tumor tissues of gastric cancer. Biochim Biophys Acta 1772: 1033-1040.